A Review of Serotonin Toxicity Data: Implications for the Mechanisms of Antidepressant Drug Action

@article{Gillman2006ARO,
  title={A Review of Serotonin Toxicity Data: Implications for the Mechanisms of Antidepressant Drug Action},
  author={P. Ken Gillman},
  journal={Biological Psychiatry},
  year={2006},
  volume={59},
  pages={1046-1051}
}
  • P. Gillman
  • Published 1 June 2006
  • Psychology, Biology, Medicine
  • Biological Psychiatry

Tables from this paper

Drug-induced serotonin syndrome: a review

The awareness of ST is crucial not only in avoiding the unintentional lethal combination of therapeutic drugs but also in recognizing the clinical picture when it occurs so that treatment can be promptly initiated.

Extracting value from case reports: lessons from serotonin toxicity

Only clonus (inducible, spontaneous or ocular), agitation, agitation, diaphoresis, tremor and hyperreflexia were needed for accurate prediction of ST as diagnosed by a clinical toxicologist, according to Professor Whyte.

Serotonin Syndrome Following Single Ingestion of High Dose Methamphetamine

Serotonin syndrome is a potentially life-threatening adverse drug reaction that may occur following therapeutic drug use, inadvertent interactions between drugs, overdose of particular drugs, or the

Serotonin Syndrome: Pathophysiology, Clinical Features, Management, and Potential Future Directions

Whether the inhibition of tryptophan hydroxylase (TPH) may provide an opportunity to pharmacologically target central 5-HT synthesis, and so develop new treatments for severe, life-threatening SS is discussed.

University of Birmingham Serotonin syndrome

Whether the inhibition of tryptophan hydroxylase (TPH) may provide an opportunity to pharmacologically target central 5-HT synthesis, and so develop new treatments for severe, life-threatening SS is discussed.

Update on recent serotonin toxicity publications including comment on , ‘ Conundrums in neurology : Diagnosing serotonin syndrome – a meta-analysis of cases ’ Au :

This exercise merely demonstrates that applying ‘meta-analysis’ to case reports, all of which are of low observational quality, simply compounds the errors, of which there are many.

Demystifying serotonin syndrome (or serotonin toxicity).

Family physicians play a key role in identifying and preventing serotonin syndrome by teaching patients to recognize symptoms and monitoring patients throughout therapy.

Perspectives on genetic animal models of serotonin toxicity

Can 5-HT3 Antagonists Really Contribute to Serotonin Toxicity? A Call for Clarity and Pharmacological Law and Order

This commentary aims to clarify misconceptions in order to aid clinical decision making when using 5-HT3 antagonists, which are unlikely to cause ST.

Serotonin syndrome after initiation of pregabalin on a stable regimen of antidepressant medication

Pregabalin with its serotonergic action has a liability to cause serotonin syndrome and should be especially kept in mind in patients with polypsychopharmacology.
...

References

SHOWING 1-10 OF 79 REFERENCES

Amitriptyline: dual-action antidepressant?

  • P. Gillman
  • Psychology, Medicine
    The Journal of clinical psychiatry
  • 2003
It may still be that amitriptyline has significant effects on serotonin when treating depression, but substantive evidence needs to be adduced for such a notion to remain convincing, or even sustainable.

Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity.

  • P. Gillman
  • Biology
    British journal of anaesthesia
  • 2005
Knowledge of the properties of these drugs will help to ensure that problems can be avoided in most clinical situations, and treated appropriately (with 5-HT(2A) antagonists for severe cases) if they occur.

Serotonin syndrome: history and risk

  • P. Gillman
  • Psychology, Medicine
    Fundamental & clinical pharmacology
  • 1998
It is proposed that more systematic national collection of toxicity data is essential in order to quantify the relative risk of serotonin syndrome with various combinations of serotonergic drugs.

The serotonin syndrome and its treatment

  • P. Gillman
  • Medicine, Psychology
    Journal of psychopharmacology
  • 1999
There is some evidence suggesting the efficacy of chlorpromazine and cyproheptadine in the treatment of serotonin syndrome, but the evidence for cypro heptamines is less substantial than that for chlor Promazine, perhaps because the dose necessary to ensure blockade of brain 5-HT2receptors is higher than that used in the cases reported to date.

Olanzapine and serotonin toxicity

It is quite possible, and indeed likely, that the features described by Haslett and Kumar are due to a SSRI withdrawal syndrome, and these features are consistent with those described in other cases of SSRIs withdrawal.

Possible neurobiological mechanisms underlying faster onset of antidepressant action.

  • P. Blier
  • Psychology, Biology
    The Journal of clinical psychiatry
  • 2001
Based on the effects of antidepressant drugs presently available, strategies to accelerate or augment the antidepressant response are described, some of which have already been examined in patients.

Relative Toxicity of Selective Serotonin Reuptake Inhibitors (SSRIs) in Overdose

This study shows SSRIs are relatively safe in overdose despite serotonin syndrome being common, and believes that cardiac monitoring should be considered in citalopram overdose, particularly with large ingestions and patients with associated cardiac disease.

The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity.

Decision rules (the Hunter Serotonin Toxicity Criteria) were developed that were simpler, more sensitive to serotonin toxicity and less likely to yield false positives.

Adverse reactions to mirtazapine are unlikely to be serotonin toxicity.

It is unclear what the human clinical correlates of this animal behavioral syndrome are, but they are not consistent with what is seen in human serotonin toxicity and there is no rationale for the synonymous use of the term “serotonin syndrome” for the clinical toxicity occurring in humans and this behavioral syndrome seen in rodents.

Moclobemide and the risk of serotonin toxicity (or serotonin syndrome).

  • K. Gillman
  • Psychology, Medicine
    CNS drug reviews
  • 2004
An informative re-interpretation of the risk of ST with all drugs, especially with the moclobemide-serotonin reuptake inhibitor (SRI) combinations mentioned in Bonnet’s review (1).
...